Search Results

Postmarket Surveillance of Vascular Closure Devices

The FDA perspective on VCDs and the importance of continued surveillance.

By Dale R. Tavris, MD, MPH, and Samantha Jacobs, BS

Access and Closure: Focus on TAVR

By Ted E. Feldman, MD, FESC, FACC, FSCAI

TAVR: Insights and Perspectives

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

Management of THV Degeneration

By Janarthanan Sathananthan, MD, and S. Jay Mathews, MD

Transcatheter Interventions for Pure AR: From Off-Label Use to Dedicated Devices

Challenges of TAVR in the treatment of pure aortic regurgitation and how dedicated devices can overcome them.

By Sara Waezsada, MD, and Tanja K. Rudolph, MD

TAVR in Patients With Aortic Stenosis and Low Surgical Risk

Evaluating new clinical trial data to better understand the benefits and limitations of TAVR in patients at low surgical risk.

By Lars Søndergaard, MD, DMSc, and Nicolo Piazza, MD, PhD

THV Expansion

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Transapical TAVR Devices

An era of rapid evolution in transcatheter aortic valve replacement technology.

By Michael A. Borger, MD, PhD; Joerg Seeburger, MD, PhD; Johannes Blumenstein, MD; David M. Holzhey, MD, PhD; and Friedrich W. Mohr, MD, PhD

Bioprosthetic Valve Fracture During ViV TAVR

A step-by-step practical guide for performing BVF to facilitate ViV TAVR.

By Ahmed Almomani, MD, and Adnan K. Chhatriwalla, MD

Reaching TAVR's Full Potential by Optimizing Postprocedure Care

Realizing the potential benefits that can be gained when clinical pathways are implemented post-TAVR.

By Christopher U. Meduri, MD, MPH; Vivek Rajagopal, MD; Jim Kauten, MD; Charles Brown IV, BA; David Alexander, PA; Edvin K. Feldt, MD; and Brian J. Potter, MD, MSc

Conduction Disturbance After TAVR

How to decide for permanent pacing and impact of new pacemakers after TAVR.

By Yasser Sammour, MD, and Samir R. Kapadia, MD

New Insights From the STS/ACC TVT Registry

What these ongoing data tell us about TAVR and future areas of interest.

By Frederick L. Grover, MD, and David R. Holmes Jr, MD